Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.070
+0.060 (2.99%)
At close: Oct 29, 2024, 4:00 PM
2.420
+0.350 (16.91%)
After-hours: Oct 29, 2024, 6:32 PM EDT
Alaunos Therapeutics Revenue
Alaunos Therapeutics had revenue of $4.00K in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $7.00K, down -99.76% year-over-year. In the year 2023, Alaunos Therapeutics had annual revenue of $5.00K, down -99.83%.
Revenue (ttm)
$7.00K
Revenue Growth
-99.76%
P/S Ratio
n/a
Revenue / Employee
$7,000
Employees
1
Market Cap
3.31M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTCRT News
- 1 year ago - Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS) - Benzinga
- 1 year ago - Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics, Inc. (TCRT) Q1 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Alaunos Therapeutics Reports First Quarter 2023 Financial Results - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023 - GlobeNewsWire